Literature DB >> 8564081

The effect of recombinant human basic fibroblast growth factor rhFGF-2 on human osteoblast in growth and phenotype expression.

S Berrada1, F Lefebvre, M F Harmand.   

Abstract

This paper describes the studies of human recombinant basic fibroblast growth factor (rhFGF-2) for its effects on human osteoblast growth and phenotype expression. During a 24-h period of treatment, rhFGF-2 highly stimulated DNA synthesis in a dose-related fashion with a maximum stimulation of 150% for 1 ng/ml. On the other hand, rhFGF-2 decreases alkaline phosphatase activity, synthesis of type I collagen, and cumulative amount of osteocalcin. Moreover, rhFGF-2 provoked a threefold increase in the amount of intracellular cAMP. Scatchard plots show the presence of two classes of [125I] rhFGF-2 receptors. This data suggests that rhFGF-2 which stimulate cell replication may act indirectly as an anabolic agent and stimulate some of the phenotypic expression markers.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564081     DOI: 10.1007/BF02634091

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  28 in total

1.  Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.

Authors:  J Bonadio; K A Holbrook; R E Gelinas; J Jacob; P H Byers
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

2.  Acidic and basic fibroblast growth factors stimulate tyrosine kinase activity in vivo.

Authors:  S R Coughlin; P J Barr; L S Cousens; L J Fretto; L T Williams
Journal:  J Biol Chem       Date:  1988-01-15       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Immunocytochemical localization of gamma-carboxyglutamic acid-containing proteins (osteocalcin) in rat bone and dentin.

Authors:  A J Camarda; W T Butler; R D Finkelman; A Nanci
Journal:  Calcif Tissue Int       Date:  1987-06       Impact factor: 4.333

5.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.

Authors:  D Moscatelli
Journal:  J Cell Physiol       Date:  1987-04       Impact factor: 6.384

6.  Effect of glucocorticoids on type I collagen synthesis, alkaline phosphatase activity, and deoxyribonucleic acid content in cultured rat calvariae.

Authors:  E Canalis
Journal:  Endocrinology       Date:  1983-03       Impact factor: 4.736

7.  Interaction of endothelial cell growth factor with heparin: characterization by receptor and antibody recognition.

Authors:  A B Schreiber; J Kenney; W J Kowalski; R Friesel; T Mehlman; T Maciag
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Parathyroid hormone induces c-fos and c-jun messenger RNA in rat osteoblastic cells.

Authors:  J C Clohisy; D K Scott; K D Brakenhoff; C O Quinn; N C Partridge
Journal:  Mol Endocrinol       Date:  1992-11

9.  Parathyroid hormone-activated calcium channels in an osteoblast-like clonal osteosarcoma cell line. cAMP-dependent and cAMP-independent calcium channels.

Authors:  D T Yamaguchi; T J Hahn; A Iida-Klein; C R Kleeman; S Muallem
Journal:  J Biol Chem       Date:  1987-06-05       Impact factor: 5.157

10.  Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine capillary endothelial cells.

Authors:  D Moscatelli
Journal:  J Cell Biol       Date:  1988-08       Impact factor: 10.539

View more
  8 in total

1.  Fibroblast growth factor-2 stimulates the proliferation of mesenchyme-derived progenitor cells from aging mouse and human bone.

Authors:  Guomin Ou; Lyndon Charles; Seth Matton; Craig Rodner; Marja Hurley; Liisa Kuhn; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-19       Impact factor: 6.053

2.  Effects of osteogenic growth factors on bone marrow stromal cell differentiation in a mineral-based delivery system.

Authors:  Linh N Luong; Janani Ramaswamy; David H Kohn
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

3.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation.

Authors:  A Montero; Y Okada; M Tomita; M Ito; H Tsurukami; T Nakamura; T Doetschman; J D Coffin; M M Hurley
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells.

Authors:  Liping Xiao; Takanori Sobue; Alycia Esliger; Mark S Kronenberg; J Douglas Coffin; Thomas Doetschman; Marja M Hurley
Journal:  Bone       Date:  2010-05-25       Impact factor: 4.398

5.  Fibroblast growth factor 2 induced proliferation in osteoblasts and bone marrow stromal cells: a whole cell model.

Authors:  Melissa A Dupree; Solomon R Pollack; Elliot M Levine; Cato T Laurencin
Journal:  Biophys J       Date:  2006-07-21       Impact factor: 4.033

6.  Fibroblast growth factor-2 and bone morphogenetic protein-2 have a synergistic stimulatory effect on bone formation in cell cultures from elderly mouse and human bone.

Authors:  Liisa T Kuhn; Guomin Ou; Lyndon Charles; Marja M Hurley; Craig M Rodner; Gloria Gronowicz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-03-26       Impact factor: 6.053

7.  Hyalocyte proliferation and ECM accumulation modulated by bFGF and TGF-beta1.

Authors:  Florian Sommer; Klaus Pollinger; Ferdinand Brandl; Barbara Weiser; Jörg Tessmar; Torsten Blunk; Achim Göpferich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-05-07       Impact factor: 3.117

8.  Lysyl oxidase propeptide inhibits FGF-2-induced signaling and proliferation of osteoblasts.

Authors:  Siddharth R Vora; Amitha H Palamakumbura; Maria Mitsi; Ying Guo; Nicole Pischon; Matthew A Nugent; Philip C Trackman
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.